| JPMORGAN EUROPEAN GROWTH & INCOME PLC (the 'Company') |
|
| Legal Entity Identifier: 549300D8SPJFHBDGXS57 |
|
| THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 October 2025 |
|
| Asml |
4.2% |
| Novartis |
3.3% |
| Siemens |
2.9% |
| Roche Holdings |
2.8% |
| Sap |
2.8% |
| Nestle |
2.6% |
| JPMorgan European Discovery Trust Plc |
2.4% |
| Safran Sa |
2.2% |
| Unicredit SPA |
2.2% |
| Allianz |
2.2% |
| Total |
27.7% |
| Excludes Investments in Liquidity stocks |
|
| Name of contact and telephone number for queries: |
|
| Paul Ainger 0044 207 742 6524 |
|
| Name of authorised company official responsible for making this notification: |
|
| Paul Winship 0044 207 742 9815 - Company Secretary |
|
| Date: 13 November 2025 |
|
| |
|